{"disease":{"id":"early-onset-alzheimer-disease","name":"early onset alzheimer disease"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06203106","title":"NYSCF Scientific Discovery Biobank","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"New York Stem Cell Foundation Research Institute","has_results":false},{"nct_id":"NCT06539169","title":"FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"xCures","has_results":false},{"nct_id":"NCT03507257","title":"Longitudinal Early-onset Alzheimer's Disease Study Protocol","phase":"","overall_status":"RECRUITING","enrollment_count":850,"lead_sponsor_name":"Indiana University","has_results":false},{"nct_id":"NCT06996730","title":"A Study of Donanemab, RG6289, or the Combination of Donanemab and RG6289 in Presenilin 1 (PSEN1) E280A Mutation Carriers for the Treatment of Autosomal-Dominant Alzheimer's Disease","phase":"PHASE2, PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":240,"lead_sponsor_name":"Banner Health","has_results":false},{"nct_id":"NCT07294586","title":"Exploratory Clinical Study and Validation of Blood Biomarkers for Alzheimer's Disease","phase":"","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"Amoneta Diagnostics SAS","has_results":false},{"nct_id":"NCT03153371","title":"Early-onset Alzheimer's Disease Phenotypes: Neuropsychology and Neural Networks","phase":"","overall_status":"COMPLETED","enrollment_count":180,"lead_sponsor_name":"University of California, Los Angeles","has_results":false},{"nct_id":"NCT04122001","title":"Effects of Electrical Stimulation on Verbal Learning in Typical and Atypical Alzheimer's Disease","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":94,"lead_sponsor_name":"Johns Hopkins University","has_results":false},{"nct_id":"NCT05231785","title":"A Study to Evaluate the Safety and Tolerability of ALN-APP in Patients With EOAD","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Alnylam Pharmaceuticals","has_results":false},{"nct_id":"NCT05655195","title":"Chronic Treatment of Alzheimer's Disease by Gamma Light and Sound Therapy","phase":"NA","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Massachusetts Institute of Technology","has_results":false},{"nct_id":"NCT06668610","title":"A Multifocal TDCS-EEG Protocol for Improving Symptoms of Mild Cognitive Impairment and Early Dementia","phase":"NA","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"University of Campania Luigi Vanvitelli","has_results":false},{"nct_id":"NCT03784300","title":"A Safety Study of PTI-125 in Healthy Volunteers","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"Pain Therapeutics","has_results":true},{"nct_id":"NCT03661034","title":"Study of Tolerability, Safety and Efficacy of Sensory Stimulation at Multiple Dose Levels to Improve Brain Function (Etude Study)","phase":"NA","overall_status":"UNKNOWN","enrollment_count":20,"lead_sponsor_name":"Cognito Therapeutics, Inc.","has_results":false},{"nct_id":"NCT03923517","title":"RHAPSODY-plus: Online Counseling for Family Caregivers of Patients With Young Onset Dementia","phase":"NA","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Technical University of Munich","has_results":false},{"nct_id":"NCT03634007","title":"Gene Therapy for APOE4 Homozygote of Alzheimer's Disease","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"Lexeo Therapeutics","has_results":false}],"total":14},"guidelines":[],"source":"Drug Landscape verified database"}